Longshine Investment Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
55
- Portfolio
-
34
- Exits
-
11

Longshine Investment General Information
Description
Founded in 2010, Lang Sheng Investment is a venture capital firm based in Shanghai, China. The firm seeks to invest in the healthcare and TMT sectors.
Contact Information
Website
www.cnlsi.com
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
- 6F, Langsheng Science&Technology Innovation Center
- Building C3, No.700 Yishan Road
- Shanghai, 200233
- China
+86 021 0000 0000
Longshine Investment Investments (55)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
SVision | 09-Mar-2023 | Later Stage VC | 000.00 | Diagnostic Equipment | Generating Revenue | |
Multitude Therapeutics | 26-Sep-2021 | 00000 00000 | Drug Discovery | Clinical Trials - General | ||
Kesairui Bio | 19-Jan-2021 | 00000 00000 | 0000 | Drug Discovery | Out of Business | |
SVision | 19-Jan-2021 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
Percans Oncology | 23-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
Hinova Pharmaceuticals | 24-Aug-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
SVision | 07-Nov-2019 | 00000 00000 | Diagnostic Equipment | Generating Revenue | ||
Hinova Pharmaceuticals | 26-Jul-2019 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
Fine Mems | 24-Jul-2019 | Later Stage VC | Electronic Equipment and Instruments | Generating Revenue | ||
Remedicine | 05-Jun-2019 | Early Stage VC | Therapeutic Devices | Generating Revenue |
Longshine Investment Exits (11)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ImmuneOnco | 05-Sep-2023 | IPO | 000.00 |
Suochen | 17-Apr-2023 | 000 | 00000 |
Zhai.me | 04-Jun-2022 | 000 00 00000000 | |
Hinova Pharmaceuticals | 12-Apr-2022 | 000 | 00000 |
Kesairui Bio | 13-Jan-2022 | 000 00 00000000 | |
Deshi Group | 01-Oct-2021 | 000000000 00000000 | |
ImmuneOnco | 09-Apr-2021 | 000000000 00000000 | 0000 |
AutocloudPro | 01-Mar-2021 | 000 00 00000000 | |
Face Touch Digital | 01-Mar-2021 | Out of Business | |
Yiguo | 21-Oct-2020 | Bankruptcy: Admin/Reorg |
Longshine Investment Investments by Industry, Year, and Region
Longshine Investment Team (6)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Francis Ping | Founding Partner, Chief Executive & Chairman, Investment Committee Officer | 0 | 0 | Shanghai, China | |
Gao Yuan | Partner | Shanghai, China | |||
Jolee Li Ph.D | Partner | Shanghai, China | |||
Lynn Zhou | Partner | Shanghai, China | |||
Songtao Sun | Partner | Shanghai, China |
Longshine Investment Co-Investors (50)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
CMB International Capital | 2 | 0 |
![]() |
![]() |
|
Kunlun Investment | 0 | 0 |
![]() |
![]() |
|
Legend Capital | 0 | 0 |
![]() |
![]() |
|
Legend Star | 0 | 0 |
![]() |
![]() |
|
Sherpa Healthcare Partners | 0 | 0 |
![]() |
![]() |